Figure 3From: Modeling the public health impact of malaria vaccines for developers and policymakers Annual malaria events averted in 40 high-burden African countries by the simulated vaccine. MVM projections of the number of A) uncomplicated cases; B) severe cases; C) deaths; D) DALYs averted by use of an 85% efficacious pre-erythrocytic vaccine with an efficacy decay rate of 4 years over 10 years in sub-Saharan Africa.Back to article page